DNDi and our partners are working to deliver safer, simpler treatments to save lives, reduce social stigma, and eliminate leishmaniasis as a public health problem. In the short term, we aim to build on our successes in delivering safer, shorter treatments with existing drugs. To bring prompt diagnosis and treatment closer to patients and help facilitate sustainable disease elimination, our longer-term goal is to develop all-new treatments with new chemical entities that are safe, effective, and easier to manage at the primary healthcare level.